Results 1 to 10 of about 5,863 (174)
Refractory Spontaneous Pneumothorax in Interstitial Lung Disease Under Pirfenidone Treatment [PDF]
Respirology Case ReportsRecurrent pneumothorax associated with interstitial lung disease occurs frequently. In the case of refractory pneumothorax, other methods such as mechanical pleurodesis, in addition to chemical pleurodesis, should be considered, because antifibrotics ...
Jaejun Jeong, Min Kyun Kang
doaj +3 more sources
The association of defective pleural sRAGE production with the recurrence of malignant pleural effusion after Talc pleurodesis [PDF]
Scientific ReportsSymptomatic malignant pleural effusions (MPE) are treated with chemical pleurodesis to prevent recurrence. The serum soluble receptor for advanced glycation end products (sRAGE) has been linked to lung cancer progression but its role in predicting talc ...
Kittipong Maneechotesuwan +4 more
doaj +2 more sources
Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion [PDF]
Tuberculosis and Respiratory Diseases, 2021 Background Pleurodesis fails in 10%–40% of patients with recurrent malignant pleural effusions malignant pleural effusion and dyspnea. This study aimed to assess the values of pleural elastance (PEL) after the aspiration of 500 mL of pleural fluid and ...
Hossam Hosny Masoud +3 more
doaj +1 more source
Journal of Association of Pulmonologist of Tamil Nadu, 2021 Abstract The aim of pleurodesis is to seal visceral to parietal pleura with adhesions to prevent pleural fluid or air accumulating. Pleurodesis is dependent upon lung re-expansion following removal of pleural fluid or air, which allows the apposition of visceral and parietal pleura.
Stephen J. Chapman +4 more
+5 more sources
Pleurodesis: A review of the indications, techniques, and complications
Journal of Association of Pulmonologist of Tamil Nadu, 2021 Pleurodesis is a procedure which obliterates the pleural cavity with the intent of preventing reaccumulation of fluid or air in the pleural cavity.
Venkata Nagarjuna Maturu +1 more
doaj +1 more source
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, 2020 Introduction. Exudative tumor pleurisy affects up to 100 000 people a year in Russia, up to 400 000 people a year in Europe. Inpatient treatment of such patients is associated with certain costs, and there are also queues for treatment in oncology ...
O. V. Ivanov +2 more
doaj +1 more source
JTCVS Open, 2021 Objective: Pleurodesis is among several treatment strategies for postoperative alveolo-pleural fistula (APF) after lung resection. Accordingly, the present study aimed to determine the influence of pleurodesis on postoperative pulmonary function. Methods:
Atsushi Kagimoto, MD +6 more
doaj +1 more source
Platelet-Rich Plasma for Pleurodesis: An Experimental Study in Rabbits
Medicina, 2022 Background and Objectives: This study was designed to evaluate platelet-rich plasma (PRP) as a method of pleurodesis in a rabbit model. Pleurodesis with PRP was compared against the gold-standard use of talc.
Styliani Maria Kolokotroni +6 more
doaj +1 more source
Egyptian Journal of Chest Disease and Tuberculosis, 2015 Background: Pleurodesis fails in 10–40% of patients with recurrent malignant pleural effusions (MPEs) and dyspnea. An accurate definition of the different characteristics of the patient would help to identify more precisely the population mostly ...
Samah M. Shehata +2 more
doaj +1 more source
Egyptian Journal of Chest Disease and Tuberculosis, 2018 Background Malignant pleural effusion (MPE) arises in advanced stages of malignancies and frequently carries a poor prognosis. The most common management of the patients with refractory MPE is pleurodesis.
Mohammed M.N AboZaid +2 more
doaj +1 more source